Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes.
about
Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTsOutcome of in vitro fertilization in women with subclinical hypothyroidism.Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?Thyroglobulin autoantibodies: is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment?Thyroid function in infertile patients undergoing assisted reproduction.Effects of Thyroid Stimulating Hormone (TSH) level on clinical pregnancy rate via In Vitro Fertilization (IVF) procedure.Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age.Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo qualitySubclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live Birth.Live birth rates following in vitro fertilization in women with thyroid autoimmunity and/or subclinical hypothyroidism.Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values.Novel correlates between antimüllerian hormone and menstrual cycle characteristics in African-American women (23-35 years-old).Levothyroxine supplementation improves serum anti-Müllerian hormone levels in infertile patients with Hashimoto's thyroiditis.
P2860
Q26851659-3A35EB34-3A4D-4B7B-8A1D-89EFDDF5B77BQ33729927-C970F136-E24C-4F39-BBEE-492B2A3B0E85Q34019271-15FFAC60-EACE-4379-BB77-C75AE2106B7FQ34327590-C204431D-A656-4611-848E-6B3E1526221CQ34334741-0885089D-0772-475B-BEA9-1A5C65A74A0EQ34451043-D543E165-A3FE-4B3E-855F-64D6DA4DB2C6Q35160855-40F1BB74-1511-41B8-ABCD-53B22BBBCCB6Q36192117-96F620D2-657B-47B5-AA32-1712096E61D6Q36965286-D81AD771-3614-443E-BA4A-9721A74E24DAQ38397360-41912BD8-1EBE-46D7-9333-46ECD7048A36Q39010108-EAB9A69F-ABBA-4397-9CB0-FBE01D9C42C5Q39822162-C53BAE68-157D-4EEE-B80F-DE1A9BF0CA23Q49343887-C1CEF6EB-729E-4E70-BB9E-3D4F24D9BE2B
P2860
Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Subclinical elevations of thyr ...... roductive technology outcomes.
@ast
Subclinical elevations of thyr ...... roductive technology outcomes.
@en
type
label
Subclinical elevations of thyr ...... roductive technology outcomes.
@ast
Subclinical elevations of thyr ...... roductive technology outcomes.
@en
prefLabel
Subclinical elevations of thyr ...... roductive technology outcomes.
@ast
Subclinical elevations of thyr ...... roductive technology outcomes.
@en
P2093
P2860
P1476
Subclinical elevations of thyr ...... roductive technology outcomes.
@en
P2093
Eric Widra
James H Segars
Kevin S Richter
Konstantinos G Michalakis
Lynae M Brayboy
Michael Levy
Tolga B Mesen
P2860
P304
P356
10.1016/J.FERTNSTERT.2011.02.056
P407
P577
2011-03-31T00:00:00Z